Weiwei Tian
Taiyuan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Impact of frailty tools on outcomes in myeloma: MRP and simplified index predict survival but differ in infection risk stratification.
Journal: Hematology (Amsterdam, Netherlands)
Published: March 09, 2026
Artificial intelligence reshaping the paradigm of hematologic malignancy diagnosis and treatment: From static assessment to dynamic precision management.
Journal: Annals of hematology
Published: December 24, 2025
Case Report: Short-course defibrotide combined with eculizumab for TA-TMA.
Journal: Frontiers in immunology
Published: December 19, 2025
Breakthroughs and challenges of CAR-T cell therapy in treating hematologic malignancies of the central nervous system.
Journal: Blood science (Baltimore, Md.)
Published: November 10, 2025
Clinical Characteristics, Treatment Patterns, and Prognosis of Central Nervous System Involvement in Multiple Myeloma: A Multicenter Retrospective Study From China.
Journal: Cancer medicine
Published: October 12, 2025
Expert Consensus on Cytomegalovirus Management in Recipients of CAR-T Cell and Bispecific Antibody Therapies.
Journal: Journal of evidence-based medicine
Published: August 11, 2025
Febrile neutropenia adversely affects chemomobilization outcomes in patients with multiple myeloma and increases risk for post-transplant infection in those with lymphoma: real-world multicenter data.
Journal: Blood science (Baltimore, Md.)
Published: July 01, 2025
Pathways of influence on health-promoting lifestyles in older adults with coronary heart disease: a cross-sectional study.
Journal: Frontiers in cardiovascular medicine
Published: June 24, 2025
Real-world outcomes of isatuximab with pomalidomide and dexamethasone for relapsed and/or refractory multiple myeloma.
Journal: Chinese medical journal
Published: December 23, 2024
Deep insight into cytokine storm: from pathogenesis to treatment.
Journal: Signal transduction and targeted therapy
Published: August 09, 2024
Development of a clinical prognostic model for primary plasma cell leukemia patients treated with novel agents: a multicenter retrospective cohort study.
Journal: Annals of hematology
Published: March 25, 2024
Infections associated with CAR-T cell therapy in patients with relapsed refractory multiple myeloma: Risks and prevention strategies.
Journal: Cancer medicine
Published: November 29, 2023
Last Updated: 09/26/2026